Vanillin extracted from Proso and Barnyard millets induce apoptotic cell death in HT-29 human colon cancer cell line

Deepa Priya Ramadoss1, Nageswaran Sivalingam1

  • 1Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.

Nutrition and Cancer
|October 13, 2019
PubMed

Insights

Compounds from Proso and Barnyard millets, identified as vanillin, inhibit colon cancer cell growth. These natural compounds induce cell cycle arrest and apoptosis, offering potential as a natural colon cancer therapy.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cancer Research

Background:

  • Proso (Panicum miliaceum) and Barnyard (Echinochloa esculenta) millets contain bioactive compounds.
  • Colon cancer is a significant global health concern, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the potential of compounds extracted from Proso and Barnyard millets to inhibit colon cancer cell proliferation and induce apoptosis.
  • To identify the chemical structure of the active compounds and assess their cytotoxic effects.

Main Methods:

  • Bioactive compounds were purified using supercritical fluid extraction.
  • Chemical structures were elucidated using spectroscopic methods.
  • Cell proliferation was assessed using MTT assay on HT-29 colon cancer cells.
  • Cytotoxicity was evaluated by lactate dehydrogenase release.
  • Apoptosis and cell cycle phases were analyzed via flow cytometry.

Main Results:

  • Extracted compounds were identified as vanillin (4-Hydroxy-3-methoxybenzaldehyde).
  • Compound 1 significantly inhibited HT-29 cell proliferation at 250 and 1,000 µg/ml.
  • Compound 2 moderately inhibited proliferation under the same conditions.
  • Compounds 1 and 2 showed no cytotoxicity at 250 µg/ml.
  • Flow cytometry revealed dose-dependent G0/G1 cell cycle arrest and increased apoptosis.

Conclusions:

  • Vanillin, extracted from Proso and Barnyard millets, exhibits significant anticancer properties against colon cancer cells.
  • The mechanism involves inhibition of cell proliferation, induction of apoptosis, and cell cycle arrest.
  • These findings suggest vanillin as a potential therapeutic agent for colon cancer derived from natural sources.